SYMYX TECHNOLOGIES INC
10-Q, EX-27.01, 2000-11-08
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SYMYX TECHNOLOGIES INC, 10-Q, 2000-11-08
Next: GUIDELOCATOR COM INC, 10QSB, 2000-11-08



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED
BALANCE SHEETS, CONDENSED STATEMENTS OF OPERATIONS AND NOTES TO CONDENSED
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          25,229
<SECURITIES>                                     6,871
<RECEIVABLES>                                    1,152
<ALLOWANCES>                                         0
<INVENTORY>                                      2,982
<CURRENT-ASSETS>                                39,098
<PP&E>                                          37,566
<DEPRECIATION>                                  11,713
<TOTAL-ASSETS>                                 141,948
<CURRENT-LIABILITIES>                           15,210
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            30
<OTHER-SE>                                     123,044
<TOTAL-LIABILITY-AND-EQUITY>                   141,948
<SALES>                                          6,116
<TOTAL-REVENUES>                                31,915
<CGS>                                            1,758
<TOTAL-COSTS>                                    1,758
<OTHER-EXPENSES>                                35,077
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 724
<INCOME-PRETAX>                                  (306)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (306)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (306)
<EPS-BASIC>                                   (0.01)
<EPS-DILUTED>                                   (0.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission